OTC and attention deficit-hyperactivity disorder: A rare, genetic disorder of urea cycle metabolism and ammonia detoxification. Ornithine transcarbamylase (OTC) deficiency neuropsychological complications include developmental delay, learning disabilities, intellectual disability, attention-deficit/hyperactivity disorder (ADHD), and executive function deficits